Darling Ingredients Launches Quali-Pure Range Of Gelatins

Darling Ingredients Inc's DAR health brand Rousselot launches Quali-Pure, a range of gelatins for biomedical applications with controlled endotoxin levels.
Quali-Pure was specifically designed for various applications, including embolization, wound healing, drug delivery, vaccines, and hemostatics.
Quali-Pure is the latest addition to the Rousselot Biomedical portfolio that consists of X-Pure biomedical gelatins, hydrolyzed gelatins, and modified gelatins.
Quali-Pure gelatins are available from October 2021, with Quali-Pure hydrolyzed gelatins to be added to the portfolio shortly.
Price Action: DAR shares are trading higher by 2.51% at $77.56 on the last check Tuesday.

Momentum73.93

Growth40.85

Quality41.81

Value57.67

Short

Medium

Long